Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON32487
NL-OMON32487
Not yet recruiting
Not Applicable

Analysis of prostrate-specific immunity in stage III and IV prostate cancer patients - Analysis of prostate-specific immunity

KI-AV0 sites50 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsprostate cancer10038597

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
prostate cancer
Sponsor
KI-AV
Enrollment
50
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
KI-AV

Eligibility Criteria

Inclusion Criteria

  • •Histologically or cytologically proven stage III or IV prostate carcinoma
  • •Age above 18 years
  • •PSA increase and/or CT/MRI confirmed progressive disease under antiandrogen treatment (including LH\-RH analogues)
  • •Performance score: WHO 0,1 or 2 at the time of study entry
  • •Written informed consent

Exclusion Criteria

  • •Concurrent treatment with immunosuppressive drugs incl. corticosteroids
  • •Undergoing any treatment other than antiandrogen therapy
  • •Severe anemia (Hb \< 6\.0 mmol/L)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Prostate cancer Immune profiling before, during and after HDR-brachytherapy in local relapsed prostate cancer.
NL-OMON48348MAASTRO clinic10
Completed
Phase 1
A Study to investigate immunogenic potential of Precision Immune Stimulants-2 (PIN-2) in Patients with Advanced Solid TumorsSolid Tumors
ACTRN12617001597381PIN Pharma Pty Ltd8
Completed
Not Applicable
Analysis of intratumoral immune response early on Nivolumab treatment in unresectable advanced or recurrent gastric cancer.nresectable advanced or recurrent gastric cancer
JPRN-UMIN000029622The University of Tokyo19
Not yet recruiting
Not Applicable
Association of immunological response with the presence or absence of oral mood stabilizers in schizophrenia patients infected with COVID-19Patients with schizophrenia
JPRN-UMIN000050395Kurita hospital50
Unknown
Not Applicable
Changes of Immunologic Function in Patients of Prostate Cancer Induced After Cryoablation.Prostate Cancer
NCT02739048Xinhua Hospital, Shanghai Jiao Tong University School of Medicine80